No. 29342 (New Rule): R58-23. Equine Viral Arteritis (EVA)  

  • DAR File No.: 29342
    Filed: 12/15/2006, 01:43
    Received by: NL

    RULE ANALYSIS

    Purpose of the rule or reason for the change:

    It is the intent of this rule to eliminate or reduce the spread of Equine Viral Arteritis (EVA) among equids by providing for a protocol for handling of equids and semens infected and/or exposed to Equine Arteritis Virus (EAV).

    Summary of the rule or change:

    This rule establishes protocol for the handling of equids and semens infected and/or exposed to EAV; requirements for approved facilities; and reporting requirements for EAV.

    State statutory or constitutional authorization for this rule:

    Subsection 4-2-2(l)(i)

    Anticipated cost or savings to:

    the state budget:

    No cost to state government. The cost will be to the owner for testing of the affected horse. Such fees are established by private veterinarians.

    local governments:

    No cost to local government. The cost will be to the owner for testing. Such fees are established by private veterinarians.

    other persons:

    The cost will be to the owner for testing of the affected horse. Such fees are established by private veterinarians.

    Compliance costs for affected persons:

    Program compliance costs will be the responsibility of the horse owner. Such fees are established by private veterinarians.

    Comments by the department head on the fiscal impact the rule may have on businesses:

    The horse industry is an integral part of agriculture. Additionally, recreational use has increased significantly in recent years. This rule is needed to protect the integrity of the horse industry and reduce the spread of disease. Leonard Blackham, Commissioner

    The full text of this rule may be inspected, during regular business hours, at the Division of Administrative Rules, or at:

    Agriculture and Food
    Animal Industry
    350 N REDWOOD RD
    SALT LAKE CITY UT 84116-3034

    Direct questions regarding this rule to:

    Terry Menlove, Kathleen Mathews, or Earl Rogers at the above address, by phone at 801-538-7166, 801-538-7103, or 801-538-7162, by FAX at 801-538-7169, 801-538-7126, or 801-538-7169, or by Internet E-mail at tmenlove@utah.gov, kmathews@utah.gov, or erogers@utah.gov

    Interested persons may present their views on this rule by submitting written comments to the address above no later than 5:00 p.m. on:

    01/31/2007

    Interested persons may attend a public hearing regarding this rule:

    1/17/2007 at 1:00 PM, Department of Agricultureal and Food, 350 N Redwood Road, Second Floor Conference Room, Salt Lake City, UT

    This rule may become effective on:

    02/07/2007

    Authorized by:

    Leonard M. Blackham, Commissioner

    RULE TEXT

    R58. Agriculture and Food, Animal Industry.

    R58-23. Equine Viral Arteritis (EVA).

    R58-23-1. Authority.

    Promulgated under authority of Title 4, Subsection 4-2-2(1)(i). It is the intent of this rule to eliminate or reduce the spread of Equine Viral Arteritis among equids by providing for a protocol for handling of equids and semen infected and/or exposed to Equine Arteritis Virus.

     

    R58-23-2. Definitions.

    (A) Accredited Veterinarian - means a veterinarian approved by the Deputy Administrator of the United States Department of Agriculture (USDA), Animal Plant Health Inspection Service (APHIS), Veterinary Services (VS) in accordance with provisions of 9 CFR Part 161.

    (B) Approved Facility - means a facility that has current written approval from the State Veterinarian to house and/or breed a carrier stallion in the state of Utah.

    (C) Approved Laboratory - means a laboratory that has been approved by the State Veterinarian.

    (D) Carrier Stallion - means any stallion that tests positive for EAV, but has no proof of a negative semen test.

    (E) Equine or Equid - means any animal in the family Equidae, including, but not limited to horses, asses, mules, ponies, and zebras.

    (F) Equine Viral Arteritis (EVA) - means an infectious disease of equids caused by Equine Arteritis Virus (EAV). The disease is characterized by abortion in pregnant mares, illness and death in young foals, inflammation of blood vessels resulting in edema and the potential of establishing a carrier state in stallions.

    (G) Equine Arteritis Virus (EAV) - means the viral organism that causes Equine Viral Arteritis.

    (H) EVA Positive - means an equid who has been identified as having tested positive to EAV.

     

    R58-23-3. Importation of Stallions.

    (A) All stallions used for breeding entering Utah shall be tested for Equine Viral Arteritis by an accredited veterinarian within 30 days prior to entry.

    (B) Exceptions to the above (R58-23-3(A)) are stallions that have proof of negative EVA status prior to vaccination and proof of subsequent yearly vaccination.

     

    R58-23-4. Importation of EVA Positive Equids and Semen.

    (A) All equids imported into Utah shall be in compliance with R58-1-6.

    (B) No EVA carrier stallion used for breeding purposes shall be permitted to enter into Utah without a prior permit from the State Veterinarian.

    (C) No semen from a carrier stallion shall be permitted to enter into Utah without a prior permit from the State Veterinarian.

    (D) All EVA Carrier Stallions, used for breeding purposes, imported into Utah shall be taken directly to an approved facility and shall remain on said facility until permission from the State Veterinarian is obtained to move the animal to another approved facility.

    (E) All semen from an EVA Carrier Stallion imported into Utah shall be shipped directly to an approved facility and shall remain on said facility until inseminated, transported to another approved facility and/or disposed of.

     

    R58-23-5. Handling of EVA Positive Equids and Semen.

    (A) All stallions used for breeding purposes identified as EVA positive shall have their semen tested by an accredited veterinarian at an approved laboratory prior to breeding of said stallion.

    (B) All carrier stallions used for breeding purposes shall be housed and maintained at an approved facility until permission from the State Veterinarian is given to move the stallion to another approved facility.

    (C) All EVA infected semen shall only be collected, handled, evaluated, received, packaged and/or administered on an approved facility.

     

    R58-23-6. Requirements for an Approved Facility.

    (A) All equids, including but not limited to stallions, mares and geldings, on approved facilities shall be vaccinated for EVA no less than 21 days before the start of breeding season or no less than 21 days before arriving at an approved facility.

    (B) Mares being bred to a carrier stallion, or inseminated with semen from a carrier stallion, shall remain on the approved facility for a minimum of 21 days after the initial breeding date.

    (C) Adequate biosecurity precautions shall be in place during the breeding season. The adequacy of biosecurity may be monitored periodically by the Utah Department of Agriculture.

     

    R58-23-7. Equine Viral Arteritis is a Reportable Disease.

    (A) All EVA positive equids shall be reported to the State Veterinarian by the private veterinary practitioner immediately upon receiving a positive laboratory report on EVA.

    (B) All EVA positive test results processed at a state owned laboratory shall be immediately reported to the State Veterinarian.

    (C) The State Veterinarian may require testing of any stallion suspected of being exposed to EAV.

     

    KEY: Equine Viral Arteritis (EVA), inspections

    Date of Enactment or Last Substantive Amendment: 2007

    Authorizing, and Implemented or Interpreted Law: 4-2-2(l)(i)

     

     

Document Information

Effective Date:
2/7/2007
Publication Date:
01/01/2007
Filed Date:
12/15/2006
Agencies:
Agriculture and Food,Animal Industry
Rulemaking Authority:

Subsection 4-2-2(l)(i)

Authorized By:
Leonard M. Blackham, Commissioner
DAR File No.:
29342
Related Chapter/Rule NO.: (1)
R58-23. Equine Viral Arteritis (EVA).